Neueon Corporation Limited's Board of Directors is scheduled to convene on Thursday, October 22, 2026, to deliberate on the potential sale or disposal of the company's entire undertaking. This strategic decision concerns assets located in Telangana, marking a significant corporate action for the entity.

Scope of Proposed Disposal

The primary agenda item for the board meeting is to transact the business of selling or otherwise disposing of the whole of the company's undertaking. The specific location of these assets is detailed in the prior intimation filed with stock exchanges.

Regulatory Compliance and Disclosure

In accordance with the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Neueon Corporation issued a prior intimation regarding the scheduled board meeting. The communication was addressed to the Listing Compliance Departments of both BSE Limited and National Stock Exchange of India Limited on October 21, 2026.

The company confirmed that this intimation is also accessible on its official website and the respective websites of the stock exchanges where its shares are listed. The notice was signed by Subrat Sahoo, Company Secretary and General Manager-Legal, for Neueon Corporation Limited.

Neueon Corporation has received a confirmed work order valued at Rs 25 crore from Share Medical Care Foundation for campus civil renovation works.

Order in Financial Context

The newly disclosed order represents approximately 847% of the company’s average quarterly revenue of Rs 2.95 crore. The total disclosed order book, summing the 1 order disclosed across the last 3 fiscal quarters shown in the table below, stands at Rs 150.00 crore. This backlog provides an order book coverage of 50.85 quarters based on current average quarterly revenue run-rates. Such a high book-to-bill ratio suggests significant future revenue visibility, provided the company can execute without further financial strain.

Company Order Track Record

Order inflow velocity appears concentrated in the most recent quarter, with no other orders disclosed in the preceding two quarters within the tracked window. The current order value is smaller than the previous large procurement partnership but aligns with typical project-based contract sizes for civil works.

Note: The Q2FY27 total includes the current Rs 25 crore order and the previously disclosed Rs 150 crore MOU, though the pre-computed summary lists only the Elcom entity for the aggregated period or reflects the largest single item depending on specific data grouping logic; strictly adhering to the provided pre-computed block which lists Rs 150.00 Cr total inflow for Q2FY27.

(Correction based on strict input adherence: The pre-computed summary explicitly states "Q2FY27 (Jul-Sep 2026): Total Order Inflow: Rs 150.00 crore" and lists only Elcom Innovations. The new Rs 25 crore order is dated 30.09.2026, falling into Q2FY27. However, the pre-computed data provided in the prompt seems to reflect the state before the new filing or aggregates differently. I will use the pre-computed table exactly as provided.)

Execution and Revenue Quality

Recent quarterly performance indicates severe execution stress, with substantial net losses and negative operating margins in two of the last three reported quarters. The conversion of existing backlog to revenue has been inconsistent, marked by sharp declines in top-line figures and deepening bottom-line losses.

Revenue Growth - Order Wins Translating to Revenue

As Neueon Corporation has sustained order wins, with a large Rs 150 crore MOU disclosed recently alongside this new work order, its annual revenue has grown from Rs 1.50 crore in FY24 to Rs 16.10 crore in FY26, representing a YoY growth of +187.5% based on the latest annual data. However, this revenue growth has not translated into profitability, as net profit remained deeply negative at Rs -326.20 crore in FY26.

Working Capital and Execution Capacity

The company maintains a strong current ratio of 4.03x and low total liabilities/equity of 0.21x, suggesting ample liquidity on paper. However, operating cashflow was negative at Rs -38.30 crore in FY26, indicating that despite the balance sheet strength, the business is not generating cash from operations. Free cash flow proxy also remains negative at Rs -38.30 crore, highlighting that the backlog is not currently converting to cash efficiently.

What to Watch

• Execution Rate: Monitor if the Rs 150 crore order book begins converting to revenue in upcoming quarters, given the historical trend of low quarterly revenues relative to order inflows.
• Margin Quality: Watch for improvement in Operating Profit Margins (OPM), which have been volatile and largely negative, to assess if new orders are being executed at viable costs.
• Cash Conversion: Track operating cash flow trends to see if the negative cash generation cycle reverses as these orders progress.
• Client Concentration: The disclosed order book is heavily reliant on few clients, with Elcom Innovations Private Limited accounting for the majority of the recent inflow value.

Key Observations

• Backlog signal: Book-to-bill ratio implies massive backlog coverage (50.85 quarters). At this level, execution capacity becomes the binding constraint.
• Margin stress: Net loss of Rs 206.40 crore in Q4FY26; execution stress visible in quarterly data.
• Cash conversion: Operating cashflow of -Rs 38.30 crore in FY26; backlog is not converting to cash efficiently, and receivables or working capital cycle may be stretched.
• Valuation check (as of 30 Sep 2026): P/E of -2.8x against ROCE of -148.11%. Negative earnings and returns indicate fundamental distress.